Please login to the form below
Duchenne muscular distrophy
This page shows the latest Duchenne muscular distrophy news and features for those working in and with pharma, biotech and healthcare.
NICE backs PTC's muscular dystrophy drug Translarna
Duchenne muscular dystrophy (DMD) patients and their families have welcomed a decision by NICE making PTC Therapeutics' Translarna available on the NHS. ... The Muscular Dystrophy UK charity described the decision as 'history in the making', and welcomed
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Featured jobs
-
Account Director, Medical Education
-
Salary TBC
-
Account Manager
-
£Competitive Salary
-
Account director
-
Competitive salary and bonus scheme
- Digital Associate Director - Medcomms
-
£65000 - £80000 per annum
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
-
Experienced medical editor
-
Competitive salary and bonus scheme
-
Senior External Communications Lead
-
£Competitive Salary
-
Scientific Director
-
£60000 - £85000 per annum, Benefits: Bonus, pension, subsidised gym and much more
- Account Director, Healthcare Communications
-
Salary TBC
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
-
Account Director
-
£Competitive Salary
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Account Manager (PR)
-
Great Benefits
-
Publications director
-
Competitive salary and bonus scheme
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
- Senior Medical Writer, MedComms Agency
-
Salary TBC
Subscribe to our email news alerts
- Novo Nordisk awakens its ‘Sleeping Beauty’
- Merck KGaA divests allergy business to Dermapharm
- US backs Sanofi’s ‘fast-track’ coronavirus vaccine
- Genital herpes vaccine candidate heads for human studies
- Bayer shares dip as Novartis gets EU okay for Beovu in wet AMD
- Bayer shares dip as Novartis gets EU okay for Beovu in wet AMD
- Introducing Nucleus POLAR™, a state-of-the-art external expert search engine and engagement management tool
- GSK pays $50m upfront to tap Immatics’ cell therapy platform
- Researchers discover new antibiotic using AI
- Bedrock Group celebrates a trio of new hires
- Tocagen merges with Forte Biosciences after brain cancer fail
- Immutep spikes on trial of its LAG-3 drug with Keytruda
PMHub
Nobull Communications
Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...
Latest intelligence
- Novo Nordisk awakens its ‘Sleeping Beauty’
- Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
- How will the Tories’ historic win shape the NHS?
- Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
- CSR 'Christmas Spirit' 2019
- OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...
Quick links
Infographics
